In the latest episode of Let’s Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases. They are

Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the

We discuss the latest efforts to advance medical research, the new possibilities spurred by artificial intelligence and the critical role of caregivers. https://www.washingtonpost.com/video/washington-post-live/rare-diseases-presented-by-harmony-biosciences/2025/02/27/fdd36eea-84a5-4166-b435-f6c7e307d8d1_video.html

Have you ever wondered why so many clinical trials fail before reaching the market? In this episode, we dive deep into the hidden challenges of

In this episode, Leanne Woelke chats with Rob Freishtat, Co-Founder and President of Uncommon Cures and former emergency physician. Rob shares his journey into the